✦ LIBER ✦

Fluconazole prophylaxis for high-risk liver transplant recipients

✍ Scribed by Nelson Kung; Neil Fisher; Bridget Gunson; Mark Hastings; David Mutimer

Book ID: 118559039
Publisher: The Lancet
Year: 1995
Tongue: English
Weight: 317 KB
Volume: 345
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(95)92014-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcomes of antifungal prophylaxis in hi

Outcomes of antifungal prophylaxis in high-risk liver transplant recipients

✍ S. Hadley; C. Huckabee; P.G. Pappas; J. Daly; J. Rabkin; C.A. Kauffman; R.M. Mer 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

Oral ganciclovir versus valganciclovir f

Oral ganciclovir versus valganciclovir for cytomegalovirus prophylaxis in high-risk liver transplant recipients

✍ R.L. Brady; K. Green; C. Frei; P. Maxwell 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB

Prophylaxis versus preemptive therapy fo

Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients

✍ Marta Bodro; Núria Sabé; Laura Lladó; Carme Baliellas; Jordi Niubó; Jose Castell 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Candidaemia in allogeneic stem cell tran

Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis

✍ Jantunen, E; Nihtinen, A; Volin, L; Juvonen, E; Parkkali, T; Ruutu, T; Anttila, 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 110 KB

Effect of prophylaxis on fungal infectio

Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients

✍ Alan Reed; Jill Boylston Herndon; Nail Ersoz; Takahisa Fujikawa; Denise Schain; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 1 views

We sought to determine whether the prophylactic use of amphotericin B products (conventional amphotericin B and liposomal amphotericin B) reduces the incidence of fungal infections in high-risk liver transplant recipients, and if so, whether this lowers the cost of care. The study sample comprised 2

Antifungal prophylaxis in liver transpla

Antifungal prophylaxis in liver transplant recipients

✍ Gregory A. Eschenauer; Simon W. Lam; Peggy L. Carver 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB

Although the overall incidence of fungal infections in liver transplant recipients has declined, these infections still contribute significantly to the morbidity and mortality of patients with risk factors for infection. Although antifungal prophylaxis has been widely studied and practiced, no conse